PHARMACY

FDA approves Teva ADHD drug

BY Alaric DeArment

JERUSALEM — The Food and Drug Administration has approved a generic drug for attention deficit hyperactivity disorder made by Teva Pharmaceutical Industries, the Israeli generic drug maker said.

Teva announced the approval of dextroamphetamine and amphetamine extended-release capsules, a generic version of Shire’s Adderall XR, in the 5 mg, 10 mg, 15 mg, 20 mg, 25 mg and 30 mg strengths. Teva sells a generic version of Adderall XR under a 2006 license and distribution agreement with Shire as part of a settlement of a patent lawsuit that Shire filed against Teva subsidiary Barr Pharmaceuticals. Teva has the right to be supplied the product by Shire until April 2014.

Generic and branded versions of the drug had sales of about $2 billion in 2012, according to IMS Health.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Reports: Google Flu Trends may have overestimated epidemic

BY Alaric DeArment

NEW YORK — Google seems to have found a nifty niche for itself with Google Flu Trends, which seeks to track the influenza outbreak by monitoring Web searches for flu-related topics, but its accuracy may be in doubt, according to published reports.

Nature reported that a comparison between data from Google Flu Trends and official surveillance data found that the Google tool had overestimated peak flu levels. Nevertheless, according to Nature, the problem is minor, and the Internet services giant will probably be able to fix it.

Traditionally, flu tracking has been the work of agencies like the Centers for Disease Control and Prevention in the United States and France’s Sentinelles network. Nature quoted a French epidemiologist as saying that newer systems for tracking flu depend too much on existing ones.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

ScriptPro wins top spot in KLAS rankings

BY Alaric DeArment

MISSION, Kan. — Pharmacy automation system manufacturer ScriptPro has received a top spot from a research firm that specializes in monitoring and reporting on the performance of healthcare vendors.

ScriptPro said the healthcare IT research firm KLAS ranked its SP Central Pharamcy Management System No. 1 in the category of Software Solutions – Pharmacy – Outpatient (Retail) in the "2012 Best in KLAS Award: Software & Services."

"We really value the KLAS ratings. They give us objective information on how we’re doing from the perspective of our customers," ScriptPro president and CEO Mike Coughlin said. "They also help focus the attention of our team on the all-important mission of continuously improving and providing products and services that we can all be proud of."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?